Vertebral Fractures and Mortality Risk in Hospitalised Patients During the COVID-19 Pandemic Emergency
Overview
Authors
Affiliations
Background And Objective: Bone fragility has been linked to COVID-19 severity. The objective of this study was to evaluate whether a diagnosis of vertebral fracture (VF) increased mortality risk in COVID-19 patients and whether this effect was greater than in those without COVID-19.
Methods: We assessed VFs by computed tomography (CT) in a cohort of 501 patients consecutively admitted to the emergency department (ED) for clinical suspicion of SARS-CoV-2 infection during the first wave of pandemic emergency. Of those, 239 had a confirmed diagnosis of COVID-19.
Results: VF prevalence was similar between COVID-19 and non-COVID-19 groups (22.2 vs. 19%; p = 0.458). Death rates were similar between COVID-19 and non-COVID-19 groups at both 30 (15.8 vs. 12.2%; p = 0.234) and 120 days (21.8 vs. 17.6%; p = 0.236). The mortality risk was higher in COVID-19 patients either with one or multiple fractures compared to those without VFs, at 30 and 120 days, but statistical significance was reached only in those with multiple VFs (30-day HR 3.03, 95% CI 1.36-6.75; 120-day HR 2.91, 95% CI 1.43-5.91). In the non-COVID-19 group, the 30-day mortality risk was significantly higher in patients either with one (HR 7.46, 95% CI 3.12-17.8) or multiple fractures (HR 6.2, 95% CI 2.75-13.98) compared to those without VFs. A similar effect was observed at 120 days. After adjustment for age, sex and bone density, mortality risk remained associated with VFs in the non-COVID-19 group only.
Conclusions: VFs were not independently associated with short-term mortality in patients with COVID-19, but they strongly increased mortality risk in those without COVID-19.
Morphometric vertebral fractures at hospitalization associate with Long COVID occurrence.
Di Filippo L, Doga M, Mangini F, Gifuni L, Sahagun S, Querini P J Endocrinol Invest. 2025; .
PMID: 39932650 DOI: 10.1007/s40618-025-02544-1.
Incidence and Outcomes of Vertebral Compression Fracture Among Patients Infected with COVID-19.
Zhang H, Balmaceno-Criss M, Fruge A, Massey P, Daniels A, Zhang A J Clin Med. 2025; 13(24.
PMID: 39768754 PMC: 11680045. DOI: 10.3390/jcm13247830.
Alghamdi F, Mokbel K, Meertens R, Obotiba A, Alharbi M, Knapp K Viruses. 2024; 16(11).
PMID: 39599809 PMC: 11599111. DOI: 10.3390/v16111694.
Acromegaly and COVID-19, lessons, and new opportunities.
Varlamov E, Fleseriu M Pituitary. 2024; 27(6):935-944.
PMID: 38819618 DOI: 10.1007/s11102-024-01404-0.
Senthinathan A, Cimino S, Jaglal S, Craven B, Tu K, Guilcher S PLoS One. 2024; 19(2):e0297384.
PMID: 38386642 PMC: 10883570. DOI: 10.1371/journal.pone.0297384.